Global Methotrexate Market Growth 2023-2029

Global Methotrexate Market Growth 2023-2029

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.

LPI (LP Information)' newest research report, the “Methotrexate Industry Forecast” looks at past sales and reviews total world Methotrexate sales in 2022, providing a comprehensive analysis by region and market sector of projected Methotrexate sales for 2023 through 2029. With Methotrexate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methotrexate industry.

This Insight Report provides a comprehensive analysis of the global Methotrexate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methotrexate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Methotrexate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methotrexate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methotrexate.

The global Methotrexate market size is projected to grow from US$ 506 million in 2022 to US$ 613.9 million in 2029; it is expected to grow at a CAGR of 613.9 from 2023 to 2029.

North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.

The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Methotrexate market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Methotrexate for Injection

Methotrexate Tablets

Segmentation by application

Used for Cancers

Used for Rheumatoid Arthritis

Used for Other Diseases

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Teva Pharmaceutical Industries

Qualitestrx (DAVA Pharmaceuticals)

Pfizer (Hospira)

Roxane Laboratories

Sine

Maoxiang

LingNan Pharmaceutical

Powerdone

Huiyu

Key Questions Addressed in this Report

What is the 10-year outlook for the global Methotrexate market?

What factors are driving Methotrexate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Methotrexate market opportunities vary by end market size?

How does Methotrexate break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.